Global AI in Drug Discovery market was valued at US$ 281 million in 2019 and is expected to reach US$ 1597.02 million by 2030, growing at a CAGR of 35.64% over the forecast period. The rising use of artificial intelligence (AI) systems aimed at reducing the overall cost of drug discovery and improving outcomes is expected to boost demand for these platforms in the pharmaceutical industry....